CH650148A5 - Composition pharmaceutique accelerant la guerison de blessures. - Google Patents
Composition pharmaceutique accelerant la guerison de blessures. Download PDFInfo
- Publication number
- CH650148A5 CH650148A5 CH5691/81A CH569181A CH650148A5 CH 650148 A5 CH650148 A5 CH 650148A5 CH 5691/81 A CH5691/81 A CH 5691/81A CH 569181 A CH569181 A CH 569181A CH 650148 A5 CH650148 A5 CH 650148A5
- Authority
- CH
- Switzerland
- Prior art keywords
- amino acids
- composition according
- composition
- gel
- isoleucine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8028554 | 1980-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH650148A5 true CH650148A5 (fr) | 1985-07-15 |
Family
ID=10515840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5691/81A CH650148A5 (fr) | 1980-09-04 | 1981-09-03 | Composition pharmaceutique accelerant la guerison de blessures. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0047647B1 (https=) |
| JP (1) | JPS5780316A (https=) |
| AU (1) | AU7486081A (https=) |
| BE (1) | BE890230A (https=) |
| CA (1) | CA1198679A (https=) |
| CH (1) | CH650148A5 (https=) |
| DE (1) | DE3173310D1 (https=) |
| DK (1) | DK390181A (https=) |
| ES (1) | ES505172A0 (https=) |
| FI (1) | FI812708L (https=) |
| FR (1) | FR2489145A1 (https=) |
| GB (1) | GB2082911B (https=) |
| IT (1) | IT1209894B (https=) |
| NZ (1) | NZ198259A (https=) |
| ZA (1) | ZA816124B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE82511T1 (de) * | 1982-04-22 | 1992-12-15 | Squibb & Sons Inc | Granulate zur verwendung bei der behandlung von wunden. |
| JPS59501159A (ja) * | 1982-06-24 | 1984-07-05 | スミス、ロバ−ト・アラン | 薬用ゲル組成物 |
| GR79380B (https=) * | 1982-09-28 | 1984-10-22 | Johnson & Johnson Prod Inc | |
| EP0137743A3 (en) * | 1983-09-13 | 1986-10-01 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Topically administrable pharmaceutical compositions |
| DD248961A1 (de) * | 1984-05-22 | 1987-08-26 | Akad Wissenschaften Ddr | Verfahren zur herstellung wundheilungsfoerdernder praeparationen |
| CH675686A5 (https=) * | 1986-06-13 | 1990-10-31 | Japan Immuno Res Lab | |
| EP0321709A3 (en) * | 1987-12-23 | 1990-04-04 | Francisco José Izundegui MacDonnell | Fast healing and binding chemical compound or curative agent for healing wounded live animal and human soft tissues inflicted by cutting edges or separating forces |
| US4871718A (en) * | 1987-12-29 | 1989-10-03 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| GB2276819B (en) * | 1993-03-23 | 1996-12-11 | Johnson & Johnson Medical | Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol |
| US5670169A (en) * | 1993-12-20 | 1997-09-23 | E.R. Squibb & Sons, Inc. | Wound hydrating gel with novel preservative system and low cytotoxicity |
| GB2291348B (en) * | 1994-07-18 | 1999-01-20 | Johnson & Johnson Medical | Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol |
| WO1998043613A1 (en) * | 1997-04-02 | 1998-10-08 | Tamaz Shalvovich Mchedlidze | Ointments for treating suppurative lesions, burns and trophic ulcers at all stages, preparation and applications of same |
| RU2165754C2 (ru) * | 1997-04-02 | 2001-04-27 | Мчедлидзе Тамаз Шалвович | Мазь для лечения гнойновоспалительных заболеваний, ожогов, воспалительных заболеваний суставов, трофических язв и длительно незаживающих ран, способ ее приготовления и способ лечения |
| RU2138250C1 (ru) * | 1997-06-23 | 1999-09-27 | ОАО "Нижегородский химико-фармацевтический завод" | Способ получения мази "диоксиколь" |
| RU2146921C1 (ru) * | 1997-11-05 | 2000-03-27 | Рязанский областной клинический кожно-венерологический диспансер | Мазевая композиция, стимулирующая регенерацию эпителия |
| RU2146923C1 (ru) * | 1997-11-05 | 2000-03-27 | Рязанский областной клинический кожно-венерологический диспансер | Средство для лечения дерматозов |
| RU2145497C1 (ru) * | 1998-04-16 | 2000-02-20 | Государственный научный центр лекарственных средств | Средство для лечения гнойно-некротических процессов |
| RU2135180C1 (ru) * | 1999-02-15 | 1999-08-27 | Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) | Мазь для заживления ран |
| AU782519B2 (en) | 1999-11-09 | 2005-08-04 | Denki Kagaku Kogyo Kabushiki Kaisha | Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same |
| WO2002094256A1 (en) * | 2001-05-23 | 2002-11-28 | Debatosh Datta | Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis |
| RU2349302C1 (ru) * | 2007-09-21 | 2009-03-20 | Виталий Георгиевич Пшеничников | Фармацевтическая композиция для наружного применения "офломелид" при гнойно-воспалительных заболеваниях |
| US10413528B2 (en) * | 2014-10-20 | 2019-09-17 | John H. Plumb | Methods to inhibit infection during wound healing with topical compositions including amino acids |
| US11285124B2 (en) | 2017-08-18 | 2022-03-29 | Calwood Nutritionals, Llc | Compositions and methods for increasing muscle mass and strength, treating skin, reducing wear and degradation from aging and exposure and improving recovery from stress such as exercise and trauma |
| RU2733714C2 (ru) * | 2017-11-07 | 2020-10-06 | Общество с ограниченной ответственностью "Трейдсервис" | Стабильная комбинированная фармацевтическая композиция диоксидина и анестетиков |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3786076A (en) * | 1966-10-13 | 1974-01-15 | J Morelle | Lipoaminoacids |
| FR2215212B1 (https=) * | 1973-01-18 | 1976-03-05 | Seperic Ch | |
| DE2438703C3 (de) * | 1974-08-12 | 1980-02-21 | Ernst Dr.Med. 4970 Bad Oeynhausen Lauven | Verwendung einer Mischung bei der Rheumabehandlung |
-
1981
- 1981-09-01 FR FR8116636A patent/FR2489145A1/fr active Granted
- 1981-09-02 AU AU74860/81A patent/AU7486081A/en not_active Abandoned
- 1981-09-02 FI FI812708A patent/FI812708L/fi not_active Application Discontinuation
- 1981-09-03 ES ES505172A patent/ES505172A0/es active Granted
- 1981-09-03 CA CA000385170A patent/CA1198679A/en not_active Expired
- 1981-09-03 ZA ZA816124A patent/ZA816124B/xx unknown
- 1981-09-03 NZ NZ198259A patent/NZ198259A/xx unknown
- 1981-09-03 CH CH5691/81A patent/CH650148A5/fr not_active IP Right Cessation
- 1981-09-03 DK DK390181A patent/DK390181A/da not_active Application Discontinuation
- 1981-09-03 JP JP56137858A patent/JPS5780316A/ja active Pending
- 1981-09-03 IT IT8149222A patent/IT1209894B/it active
- 1981-09-04 BE BE0/205872A patent/BE890230A/fr not_active IP Right Cessation
- 1981-09-04 EP EP81304053A patent/EP0047647B1/en not_active Expired
- 1981-09-04 GB GB8126836A patent/GB2082911B/en not_active Expired
- 1981-09-04 DE DE8181304053T patent/DE3173310D1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3173310D1 (en) | 1986-02-06 |
| BE890230A (fr) | 1982-01-04 |
| EP0047647A2 (en) | 1982-03-17 |
| FI812708A7 (fi) | 1982-03-05 |
| CA1198679A (en) | 1985-12-31 |
| FR2489145B1 (https=) | 1984-05-25 |
| EP0047647B1 (en) | 1985-12-27 |
| AU7486081A (en) | 1982-03-11 |
| ZA816124B (en) | 1982-09-29 |
| IT8149222A0 (it) | 1981-09-03 |
| IT1209894B (it) | 1989-08-30 |
| ES8307491A1 (es) | 1983-07-01 |
| FI812708L (fi) | 1982-03-05 |
| GB2082911A (en) | 1982-03-17 |
| EP0047647A3 (en) | 1982-09-15 |
| JPS5780316A (en) | 1982-05-19 |
| ES505172A0 (es) | 1983-07-01 |
| FR2489145A1 (fr) | 1982-03-05 |
| DK390181A (da) | 1982-03-05 |
| NZ198259A (en) | 1985-05-31 |
| GB2082911B (en) | 1984-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH650148A5 (fr) | Composition pharmaceutique accelerant la guerison de blessures. | |
| US4438100A (en) | Sterilized preserved, stable mucine-containing solutions | |
| CA1330307C (fr) | Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol | |
| EP0233429B1 (fr) | Composition pharmaceutique contenant une association de collagène et d'un principe actif antiseptique et/ou anti-inflammatoire et son procédé de fabrication | |
| FR2509613A1 (fr) | Medicament a base d'insuline pour le traitement du diabete sucre | |
| FR3035790A3 (fr) | Preparation dentaire a base d'hyaluronane et de dichlorhydrate d'octenidine | |
| EP1434595A1 (en) | Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom | |
| US20230082131A1 (en) | Compositions including amelogenin and uses thereof | |
| US9782458B2 (en) | Composition for tissue/cell repair | |
| RU2080871C1 (ru) | Средство, обладающее регенеративной активностью | |
| FR2729568A1 (fr) | Composition a base d'argile verte pour applications ou enveloppements corporels | |
| JPH07267855A (ja) | グルタミン産生剤 | |
| RU2640930C1 (ru) | Способ лечения красного плоского лишая в полости рта | |
| TW200538150A (en) | Encapsulated peptide copper complexes and compositions and methods related thereto | |
| TWI754324B (zh) | 促進血管增生之短鏈胜肽組合物及其於糖尿病傷口癒合之用途 | |
| RU2744457C1 (ru) | Способ получения иммобилизованного ферментного препарата на основе фицина, гиалуроновой кислоты и полисахаридов, модифицированных виниловыми мономерами | |
| US20250195567A1 (en) | Compositions for removing microbial biofilm or inhibiting formation thereof | |
| CN114057831B (zh) | 促进血管增生的短链胜肽及其促进糖尿病伤口愈合的用途 | |
| CN1515315A (zh) | 一种含表皮生长因子和白及的稳定组合物 | |
| MC1044A1 (fr) | Médicament antimicrobien | |
| WO2025132610A1 (en) | Composition comprising amino acids, metabolizable and lipid component | |
| US20230310538A1 (en) | Tissue repair and wound healing composition and method using low molecular weight hydrolyzed collagen | |
| US20250041376A1 (en) | Wound healing and tissue repair composition and method | |
| US20240207351A1 (en) | Tissue repair and wound healing composition and method using low molecular weight hydrolyzed collagen | |
| JPH07118165A (ja) | カルシトニン遺伝子関連ペプチド類を含有する経皮吸収組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |